Incidence of pneumonitis following the use of different anaplastic lymphoma kinase tyrosine kinase inhibitor regimens: An updated systematic review and meta‐analysis

OBJECTIVES: Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK TKIs) have shown remarkable clinical activity in patients with non‐small‐cell lung cancer (NSCLC). However, pneumonitis is a serious side effect of ALK TKIs in NSCLC patients. In this meta‐analysis, we aimed to determine the inci...

Descripción completa

Detalles Bibliográficos
Autores principales: Qie, Wenting, Zhao, Qian, Yang, Linlin, Zou, Bing, Duan, Yanan, Yao, YueYuan, Wang, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
REVIEW
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358266/
https://www.ncbi.nlm.nih.gov/pubmed/37017467
http://dx.doi.org/10.1002/cam4.5913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358266/
https://www.ncbi.nlm.nih.gov/pubmed/37017467
http://dx.doi.org/10.1002/cam4.5913

Ejemplares similares